Skip to main content
Clinical Trials/NCT02840214
NCT02840214WithdrawnPhase 1

Impact of Transcranial Direct Current Stimulation on Fatigability and Fatigue Induced by a Selective Attention Task

University of Colorado, Denver1 site in 1 countryStarted: July 21, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Withdrawn
Locations
1
Primary Endpoint
Change in cognitive performance fatigability

Study Overview

Brief Summary

This research project is focusing on changes in mental fatigue due to transcranial direct current stimulation (tDCS) in healthy individuals. The study aim is to see if mental fatigue can be rescued by administering a safe dose of tDCS. tDCS has been shown to decrease fatigue in healthy individuals experiencing extended wakefulness, and the investigators aim to investigate if similar results can be found in a fatigue inducing task. This is a single-blind randomized control trial that will compare mental fatigue between tDCS treatment and sham treatment groups through both subjective and objective measures. Objective fatigue will be measured by reaction time with the Stroop test and subjective fatigue will be measured by the multidimensional fatigue inventory questionnaire.

Detailed Description

Right handed healthy individuals aged 18-40 will be eligible to participate. Participants will be randomized in a 1:1:1 ratio to receive real or placebo 2mA tDCS delivered for 20 minutes while performing a 3 hour computerized cued Stroop task. Groups will receive real or sham stimulation during the first 20 minutes or 90-110 minutes into the task. Groups will be: 1) Sham (sham given at both time points); 2) Prevent (real will be given during first 20 minutes to try to prevent or delay fatigue and sham given at second time point); or 3) Rescue (sham will be given initially and real given at 90-110 minutes to see if performance can be rescued after fatigue has set in). The primary outcome measure will be the slope of change for intra-individual variability of response time for correct items and regression models will be used to determine whether real preventative or rescue tDCS alters the rate of performance change relative to sham stimulation. Accuracy and mean response time will also be examined as secondary outcomes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •right-handed
  • •normal or corrected-normal vision,

Exclusion Criteria

  • •pregnant women,
  • •history of medical conditions associated with fatigue, including, but not limited to:
  • •Parkinson's disease,
  • •Alzheimer's disease,
  • •diabetes mellitus,
  • •hypothyroidism,
  • •chronic fatigue syndrome,
  • •infectious mononucleosis,
  • •irritable bowel syndrome

Arms & Interventions

tDCS rescue group

Active Comparator

Subjects assigned to this arm will receive transcranial direct current stimulation (tDCS) that delivers a constant, small current (2 milliAmp) across specific regions of the brain through electrodes placed on the scalp half-way through the 3-hour fatigue task.

Intervention: transcranial direct current stimulation (Device)

Sham Treatment Group

Placebo Comparator

Subjects assigned to this arm will initially receive current of the same intensity for a period of 30 seconds and then gradually turned off.

Intervention: sham tDCS (Device)

tDCS prevent group

Active Comparator

Subjects assigned to this arm will receive transcranial direct current stimulation (tDCS) that delivers a constant, small current (2 milliAmp) across specific regions of the brain through electrodes placed on the scalp at the beginning of the task.

Intervention: transcranial direct current stimulation (Device)

Outcomes

Primary Outcomes

Change in cognitive performance fatigability

Time Frame: over 3 hours of a single fatigability task (one time visit study)

This will be measured by change in intraindividual variability of reaction time from the Stroop Fatigue Paradigm which will be quantified as the rate of change in mean reaction time over 3 hours modeled using linear regression.

Secondary Outcomes

  • Change in perceived fatigue(Baseline then every 30 minutes for 3 hours)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Impact of Transcranial Direct Current... | Clinical Trial